Pharvaris Pharma (PHVS) - Uzoq muddatli qarzning kapitalga koeffitsiyenti
Pharvaris N.V. (PHVS) kompaniyasining 0.00 darajasida bo'lgan vizuallashtirilgan narxlar dinamikasi kamyob dori vositalari sertifikatsiyasining murakkabligi va ulkan xavfsizlik xarajatlari bilan bog'liqdir. O'sish irsiy angioedemaga qarshi innovatsion davolash usullarining yakuniy bosqichdagi sinovlari bilan qo'llab-quvvatlanmoqda. Biznes og'riqli inyeksiyalarni almashtirish va o'z segmentida ustunlikni ta'minlashga qaratilgan qulay tabletkalarning joriy etilishiga tayanadi.
%20Uzoq%20muddatli%20qarzning%20kapitalga%20nisbati&width=1200&height=400&colorIndex=0&v=mvvwvvs9.gq-7b28iyo&start=20220704&end=20261031&filename=GURU_Markets_-_PHVS_-_Pharvaris-N.V._-_Long-Term-Debt-to-Capital "PHVS: Pharvaris Uzoq muddatli qarzning kapitalga nisbati 04.07.2022 - 31.10.2026 | 👁️GURU.Markets👁️")
Pharvaris N.V. (PHVS) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi ko'rsatkichlari:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Pharvaris N.V.|PHVS - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati pharvaris.com|PHVS - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati Pharvaris N.V.|PHVS - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz hajmi Pharvaris|Tezkor likvidlik ko‘rsatkichi pharvaris.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
Kompaniyaning umumiy tahlili:Pharvaris NV - PHVS
Pharvaris N.V. (PHVS) kompaniyasining uzoq muddatli qarzdorlikning kapitalga nisbati koeffitsientini tahlil qilish faqat ichki ishlanmalarga tayanadigan kompaniyaning moliyaviy barqarorligini baholash imkonini beradi. Ushbu koeffitsient bir yildan ortiq muddatga ega majburiyatlarni kapital bilan solishtiradi, bunda past qiymatlar kredit bosimining yo'qligini tasdiqlaydi va kompaniyani sanoat gigantlari uchun jozibador sotib olish nishoniga aylantiradi.
Muhim raqobatchilar
argenx N.V. - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati BNTX|ABVX (Abivax S.A.) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati ADMA (ADMA Biologics)|Uzoq muddatli qarzning kapitalga nisbati protagonist-inc.com PTGX|IMVT - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti KNSA (Kiniksa Pharmaceuticals, Ltd.)|Grifols Group (GRFS) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Adaptive Biotechnologies Inc.|CLDX (Celldex Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati auriniapharma.com|Uzoq muddatli qarzning o'z kapitaliga nisbati BCRX (BioCryst Pharmaceuticals)|VERA (Vera Therapeutics Inc) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati DNTH (Dianthus Pharma)|Uzoq muddatli qarzdorlikning kapitalga nisbati AbCellera (ABCL)|TRML - Uzoq muddatli qarzning o'z kapitaliga nisbati|precigen.com (PGEN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Pharming Group (PHAR) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Nektar Therapeutics Inc|Uzoq muddatli qarzning o'z kapitaliga nisbati UPB|Uzoq muddatli qarzning kapitalga nisbati Zenas Corp|Uzoq muddatli qarzning o'z kapitaliga nisbati Immunome, Inc. (IMNM)|gossamerbio.com - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati KALV (KalVista Pharmaceuticals, Inc.)|Septerna, Inc. (SEPN) - Uzoq muddatli majburiyatlarning kapitalga nisbati|PVLA - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati SVRA|RIGL: Uzoq muddatli qarzning kapitalga nisbati|anaptysbio.com - Uzoq muddatli qarzning kapitalga koeffitsiyenti|ATXS (Astria Therapeutics, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati enGene Holdings Inc|Uzoq muddatli qarzning o'z kapitaliga nisbati RAPT Therapeutics, Inc. (RAPT)|JBIO (aerovatetx.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Aclaris Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|kyvernatx.com - Uzoq muddatli qarzning o'z kapitaliga nisbati|Tiziana Life Sciences Ltd - Uzoq muddatli qarzning kapitalga nisbati|CABA - Uzoq muddatli qarzning kapitalga nisbati|Ventyx Bio (VTYX) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Theratechnologies, Inc - Uzoq muddatli qarzning kapitalga koeffitsiyenti|AVTX (Avalo Therapeutics, Inc) - Uzoq muddatli qarzning kapitalga nisbati|eledon.com (ELDN) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Agenus Inc. (AGEN)|Uzoq muddatli qarzdorlikning kapitalga nisbati Climb Bio Inc.|Zura Bio Limited - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti ATYR|ADAG - Uzoq muddatli qarzning o'z kapitaliga nisbati|IMA (ImageneBio Inc) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|STTK (shattucklabs.com) - Uzoq muddatli qarzning o'z kapitaliga nisbati|EQ - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati CNTB|Uzoq muddatli qarzning o'z kapitaliga nisbati IMUX|Uzoq muddatli qarzning o'z kapitaliga nisbati ATRA (Atara Biotherapeutics)|Uzoq muddatli qarzdorlikning kapitalga nisbati inflarx.de|Uzoq muddatli qarzning o'z kapitaliga nisbati X4 Pharmaceuticals, Inc. XFOR|ACET (Adicet Bio Inc.) - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Celularity Corp - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti INMB (INmune Bio Corporation)|BRNS (Barinthus Biotherapeutics) - Uzoq muddatli qarzning o'z kapitaliga nisbati|KZR (kezarlifesciences.com) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati SAB Biotherapeutics, Inc.|Akari Therapeutics PLC (AKTX) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Enlivex Therapeutics (ENLV)|QTTB: Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati GOVX (GeoVax Labs, Inc.)|Uzoq muddatli qarzning kapitalga koeffitsiyenti EDSA|iBio - Uzoq muddatli qarzning kapitalga nisbati|CARM - Uzoq muddatli qarzning kapitalga nisbati|XTL Biopharmaceuticals, Ltd. (XTLB) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Bolt Biotherapeutics, Inc. - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati HCW Biologics, Inc.|Uzoq muddatli qarzning o'z kapitaliga nisbati Aptevo (APVO)|Uzoq muddatli qarzning kapitalga nisbati AIM|Uzoq muddatli qarzning kapitalga nisbati aditxt.com (ADTX)|GRI Bio Corp - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti XRTX|Vyome Holdings Inc - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati revbiosciences.com REVB|Indaptus Therapeutics, Inc. (INDP) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Scinai Immunotherapeutics Ltd|Uzoq muddatli qarzning o'z kapitaliga nisbati CalciMedica Inc|Uzoq muddatli qarzning o'z kapitaliga nisbati Affimed Therapeutics (AFMD)|Uzoq muddatli qarzning o'z kapitaliga nisbati ALLK (Allakos Inc.)|Uzoq muddatli qarzning kapitalga nisbati hookipapharma.com (HOOK)|Uzoq muddatli qarzning o'z kapitaliga nisbati IGM Biosciences IGMS|ITOS: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Ocean Bio - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati TC BioPharm Ltd|Third Harmonic Bio (THRD) - Uzoq muddatli qarzning o'z kapitaliga nisbati